LLY

757.36

+3.2%↑

JNJ

151.29

+1.18%↑

UNH

291.24

+6.59%↑

ABBV

183.96

+1.27%↑

NVO

64.34

-2.56%↓

LLY

757.36

+3.2%↑

JNJ

151.29

+1.18%↑

UNH

291.24

+6.59%↑

ABBV

183.96

+1.27%↑

NVO

64.34

-2.56%↓

LLY

757.36

+3.2%↑

JNJ

151.29

+1.18%↑

UNH

291.24

+6.59%↑

ABBV

183.96

+1.27%↑

NVO

64.34

-2.56%↓

LLY

757.36

+3.2%↑

JNJ

151.29

+1.18%↑

UNH

291.24

+6.59%↑

ABBV

183.96

+1.27%↑

NVO

64.34

-2.56%↓

LLY

757.36

+3.2%↑

JNJ

151.29

+1.18%↑

UNH

291.24

+6.59%↑

ABBV

183.96

+1.27%↑

NVO

64.34

-2.56%↓

Search

NeoGenomics Inc

Slēgts

8.09 2.93

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

7.7

Max

8.14

Galvenie mērījumi

By Trading Economics

Ienākumi

-11M

-26M

Pārdošana

-4M

168M

EPS

-0.204

Peļņas marža

-15.427

Darbinieki

2,200

EBITDA

-10M

-6.3M

Rekomendācijas

By TipRanks

Rekomendācijas

Pirkt

Prognoze 12 mēnešiem

+75.64% upside

Dividendes

By Dow Jones

Nākamie ieņēmumi

2025. g. 28. jūl.

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

-188M

1.1B

Iepriekšējā atvēršanas cena

5.16

Iepriekšējā slēgšanas cena

8.09

Tehniskais rādītājs

By Trading Central

Pārliecība

Very Strong Bearish Evidence

NeoGenomics Inc Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2025. g. 15. maijs 17:16 UTC

Peļņas
Galvenie tirgus virzītāji

Bitcoin Depot Shares Rise After 1Q Beat

2025. g. 13. maijs 14:39 UTC

Iegādes, apvienošanās, pārņemšana

Robinhood Markets to Buy Canada's WonderFi Technologies for C$250 Million

2025. g. 12. maijs 15:57 UTC

Galvenie tirgus virzītāji
Iegādes, apvienošanās, pārņemšana

KindlyMD Skyrockets on Merger With Nakamoto to Make Bitcoin Treasury

2025. g. 9. maijs 11:25 UTC

Peļņas

TeraWulf 1Q Loss Widens After Bitcoin Halving Cuts Revenue

2025. g. 15. maijs 20:37 UTC

Peļņas

SOS Ltd: Growth Was Fueled by Robust Domestic Demand and Expansion of Pdt Portfolio to Include Rubber and Coal >SOS

2025. g. 15. maijs 20:37 UTC

Peļņas

SOS Ltd: Cryptocurrency Mining Rev Declined to $9.3M From $18.9M in FY23, Dip Was Attributed to the Temporary Shutdown of Texas Mining Facility for Upgrades During 1H 2024 >SOS

2025. g. 15. maijs 20:37 UTC

Peļņas

SOS Ltd: FY24 Significant Yr-over-Yr Increase in Commodity Trading Rev, Which Soared to $214.3M FY24, 92.6% of Total Rev Up From 74.0% in FY23 >SOS

2025. g. 15. maijs 20:37 UTC

Peļņas

SOS Ltd: Cryptocurrency Mining Rev Halves as SOS Focuses on Facility Upgrades and Commodity Expansion >SOS

2025. g. 15. maijs 13:21 UTC

Iegādes, apvienošanās, pārņemšana

SRx Health Solutions to Form Crypto Treasury Subsidiary With Plan to Partner With Industry Leader

2025. g. 15. maijs 13:20 UTC

Iegādes, apvienošanās, pārņemšana

SRx Health Solutions Further Diversifies Treasury Strategy With Purchase of Bitcoin

2025. g. 15. maijs 12:30 UTC

Tirgus saruna

Bitcoin Stays Lower as Risk Appetite Wanes -- Market Talk

2025. g. 15. maijs 12:04 UTC

Iegādes, apvienošanās, pārņemšana

DeFi Development Purchases 16,447 Solana for $2.3M

2025. g. 15. maijs 09:00 UTC

Top Ziņas

Democrats Want Answers From Trump on Binance CEO's Pardon Push -- WSJ

2025. g. 15. maijs 08:14 UTC

Tirgus saruna

Global Forex and Fixed Income Roundup: Market Talk

2025. g. 15. maijs 08:14 UTC

Tirgus saruna

Bitcoin Falls as Tariff Uncertainties Dampen Risk Appetite -- Market Talk

2025. g. 14. maijs 14:19 UTC

Top Ziņas

CFTC Commissioner to Join Crypto Industry Lobbying Group as CEO

2025. g. 14. maijs 08:19 UTC

Tirgus saruna

Bitcoin Falls as Global Trade Uncertainties Persist -- Market Talk

2025. g. 13. maijs 07:14 UTC

Tirgus saruna

Bitcoin Pulls Back After Gains on U.S.-China Trade Progress -- Market Talk

2025. g. 12. maijs 11:41 UTC

Tirgus saruna

Market Talk Roundup: Latest on U.S. Politics

2025. g. 12. maijs 11:41 UTC

Tirgus saruna

Bitcoin Cuts Gains After Surge Following U.S.-China Tariff Deal -- Market Talk

2025. g. 12. maijs 07:59 UTC

Tirgus saruna

Bitcoin Rises on U.S, China Agree to Cut Tariffs -- Market Talk

2025. g. 9. maijs 15:13 UTC

Peļņas
Iegādes, apvienošanās, pārņemšana

Coinbase Stock Is Down After Earnings as Bitcoin Keeps Rising -- Barrons.com

2025. g. 9. maijs 12:56 UTC

Peļņas

These Stocks Are Moving the Most Today: Coinbase, Expedia, Affirm, Lyft, Cloudflare, Microchip, Pinterest, and More -- Barrons.com

2025. g. 9. maijs 12:40 UTC

Peļņas
Iegādes, apvienošanās, pārņemšana

Coinbase Stock Drops After Earnings. Why Bitcoin $100K, Deribit Acquisition Aren't Boosting Shares. -- Barrons.com

2025. g. 9. maijs 11:55 UTC

Tirgus saruna

Global Forex and Fixed Income Roundup: Market Talk

2025. g. 9. maijs 11:55 UTC

Tirgus saruna

Bitcoin's High Price Bodes Well for Crypto, Boosts Demand for Ethereum -- Market Talk

2025. g. 9. maijs 11:26 UTC

Peļņas

These Stocks Are Moving the Most Today: Coinbase, Expedia, Affirm, Lyft, Cloudflare, Microchip, Pinterest, and More -- Barrons.com

2025. g. 9. maijs 10:03 UTC

Top Ziņas

Investors Dig Into U.K. Trade Deal, Await News of China Talks -- WSJ

2025. g. 9. maijs 08:17 UTC

Tirgus saruna

Bitcoin Rises to Three-Month High as U.K.-U.S. Trade Deal Sparks Optimism -- Market Talk

2025. g. 8. maijs 22:16 UTC

Peļņas

Coinbase Posts Mixed Earnings Results That Missed Forecasts. The Stock Is Down. -- Barrons.com

Salīdzinājums

Cenas izmaiņa

NeoGenomics Inc Prognoze

Cenas mērķis

By TipRanks

75.64% augšup

Prognoze 12 mēnešiem

Vidējais 13.77 USD  75.64%

Augstākais 26 USD

Zemākais 8.5 USD

Pamatojoties uz 15 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi NeoGenomics Inc — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt

15 ratings

9

Pirkt

6

Turēt

0

Pārdot

Tehniskais rādītājs

By Trading Central

7.7 / 10.27Atbalsts un pretestība

Īstermiņā

Very Strong Bearish Evidence

Vidējā termiņā

Bearish Evidence

Ilgtermiņā

Bearish Evidence

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par NeoGenomics Inc

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. It operates through Clinical Services and Advanced Diagnostics segments. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company also provides molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization. NeoGenomics, Inc. was founded in 2001 and is headquartered in Fort Myers, Florida.